Trademarkia Logo

United Kingdom

£
Application Published

on 8 Mar 2022

Last Applicant/ Owned by

NeuExcell Therapeutics Inc.

401 N. Broad St., Suite 242

Philadelphia, , PA 19108

Serial Number

UK00003763122 filed on 8th Mar 2022

Correspondent Information

Hansel Henson Limited

3rd Floor, 8 Bloomsbury Street

London,

WC1B 3SR

NEUEXCELL

pharmaceuticals for treating alzheimer’s disease, parkinson’s disease, amyotrophic lateral sclerosis (als), huntington’s disease, epilepsy, physical i Read More

Classification Information


Class [5]
Pharmaceutical Products


Pharmaceuticals for treating Alzheimer’s Disease, Parkinson’s Disease, amyotrophic lateral sclerosis (ALS), Huntington’s Disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, and cerebral venous sinus thrombosis.

Mark Details


Serial Number

UK00003763122

Mark Type

Word

Kind of mark

Individual